analysis, tumours in the tonsillar region were associated with better survival. However, on multivariate analysis other factors, i.e. midline origin of the tumour, a revised staging system and sex, emerged statistically as more significant than the subsite.18
The revised staging system, mentioned here, comprises a modified combination of the existing TNM categories for this patient population (Table 1) , which was compared with the current UICC'92/AJCC'88 staging system.19 This revised stag ing seems to provide a better prognostic discrimination for disease-specific survival. The relevance of the revised staging on different subsites in this series and/or on other large series remains to be verified, but it seems obvious that the present staging systems are not yet optimal.
at the time of death or at the end o f the follow-up. Three analyses were performed. In all multivariate analyses the proportional hazard model and locoregional control are investigated and the effects of was used. P-values were calculated from the likelihood ratio the revised staging system are further analysed.
statistics. Univariate curves were com puted using the life table method with 1-month intervals or the product-limit method. 18.20.21 In this paper carcinoma of the tonsillar region is studied as a single clinical entity. Treatment results in terms o f survival
Patients and methods
Adjusted curves were calculated from the cumulative hazard function, estimated according to the method of Link.22 The variable for which the curves had to be calculated was used as stratum variable, whereas the variables that had to be adjusted for were included in the model as covariates. The curves were calculated at approximate mean values of the covariates in the whole group. At 5 yr the overall survival was 32% and the disease-specific survival 42%, As can be seen from Figure 2 , the diseasespecific survival in patients treated with radiotherapy alone was 39%, with surgery and radiotherapy 53%, and with sur gery alone 83%.
The disease-specific survival in both staging systems, shown and for five patients (2%) the intention to treat was not known in Figure 3 , ranged from 71% in stage I to 32% in stage IV in retrospect. The treatment corresponded to the standard (P < 0.0001) of the UICC'92 system and from 63% to 9% protocol in operation in the participating centres in 325 pa-(P < 0.0001) in the corresponding stages of the revised system, tients (85%), was different from the standard in 52 patients (14%) and was unknown in the remaining three patients (1 %).
,,,
The main reasons for deviating from the standard treatment were poor general condition in 15 patients (4%) and refusal The status at the end of the follow-up is shown in Table 2 . in 10 patients (3%); in all other patients but one (refusing The locoregional control at 5 yr was 61%. By treatment standard treatment because o f age), multiple reasons for devimodality the 5-yr figures were 54% for radiotherapy alone, ating from the standard protocols were given.
74% for surgery and radiotherapy, and 96% for surgery alone Two hundred and thirty-one patients (61%) were treated ( Figure 4 ). with radiotherapy alone, 101 (27%) with surgery and radio therapy, 30 (8%) with surgery alone, five patients (2%) with chemotherapy alone, and the remaining 13 patients (3%) did not receive any treatment. The group o f 231 patients treated with radiotherapy alone also includes 27 patients who received primary radiotherapy but also underwent a neck dissection. These patients, the majority of whom had (UICC'92) stage III-IV disease will be discussed separately. The treatment When analysed separately, the 27 patients who underwent neck dissection followed by radiotherapy to the primary site, appeared to have a 5-yr disease-specific survival of 48% and a locoregional control of 75%. Locoregional control by UICC'92 stage was: 92% in stage I, 75% in II, 66% in III and 47% in IV (P < 0.0001; Figure 5 ). In the revised staging sys tem the corresponding figures were 78%, 65%, 43% and 25% when compared to most other subsites in the oropharynx. The clinical relevance of the revised system is also indicated by the distribution of treatment modalities over the stages: in tumour control very reliably. 1, 8, 10, 23, 24 Upon residual disease and excluding those patients from further the revised version surgery alone was used only in stages I-II comparison, similar control rates were obtained with both and a steady increase of patients treated with radiotherapy modalities, alone was observed from stage I to IV. In contrast, in the The issue of selecting patients for surgery based on good UICC'92 system, seven patients in stage III and IV still performance status cannot be addressed in this study, since received surgery as their only treatment modality.
these data, as in many other series, were not available. As Also the range of the disease-specific survival and locostated previously,17 the standardized checklists designed for regional control in the four stages was wider in the revised this project only included well-defined, categorized basic data, staging compared to the UICC'92 system. However, multithat were likely to be present in all or almost all patients' variate analysis has shown a similar prognostic effect of both records. Despite the obvious importance of host characstaging systems when locoregional control was taken as the teristics in choosing treatment and predicting survival,16,25,26 a end-point. These results are somewhat different from the out come of the analysis of all patients with oropharyngeal car cinoma having survival as the end-point. In that case the revised staging seemed to be superior to the UICC'92 system.18 systematic and structured inclusion of these items in patients' records and study questionnaires has not been widely adopted. In this particular study we do know that in many clinics primary radiotherapy was often the therapy of choice, parHowever, the revised system was optimized for disease-specific ticularly in the lower UICC'92 stages. survival in that patient group, so an unbiased comparison with other staging systems can only be performed in an inde pendent sample of patients. In testing the interaction of treat ment and stage, the relatively small group of 30 patients treated with surgery alone, was omitted from the analysis. It is obvious that this subgroup selection on favourable prognostic parameters (low age, good performance status, wide margins) plays too great a role for meaningful comparison. Inter estingly, the difference in locoregional control between radioIn conclusion, the revised staging provided a shift o f pa tients with tonsillar carcinoma towards lower stages and a wider spread of survival and locoregional control curves, when compared to the UICC'92 system. In the multivariate analysis of the prognostic factors, the revised staging appeared to be comparable to the UICC'92 staging system, but not superior to it. Treatment results of the combination of surgery and radiotherapy were significantly better than those of radio therapy alone, also when adjusted for stage. Whether this is 
